CYPRIUM THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Jun 2024)
What this means for you
Registered since 04 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87978937
- Registration number
- 5624302
- Mark type
- Stylized text
- Filed
- 15 Mar 2017
- Published for opposition
- 13 Feb 2018
- Registered
- 04 Dec 2018
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Development of pharmaceutical preparations and medicines for the treatment of diseases and disorders where copper deficiency is present; Development of pharmaceutical preparations and medicines for the treatment of hematological and neurological disorders; [ Laboratory research services relating to pharmaceuticals; ] Medical research services; Pharmaceutical drug development services; Scientific research for medical purposes in the field of Menkes disease and copper transport and metabolism diseases and disorders; Scientific research for medical purposes in the field of diseases and disorders where copper deficiency is present; Scientific research for medical purposes in the field of hematological and neurological disorders [ ; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals ]
Owner
- Cyprium Therapeutics, Inc., New York, NY, US
- Cyprium Therapeutics, Inc., New York, NY, US
- Cyprium Therapeutics, Inc., New York, NY, US
Prosecution history
- 10 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Jun 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Dec 2023 — TEAS SECTION 8 & 15 RECEIVED
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Oct 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Sept 2018 — USE AMENDMENT FILED
- 25 Oct 2018 — DIVISIONAL PROCESSING COMPLETE
- 24 Sept 2018 — DIVISIONAL REQUEST RECEIVED
- 26 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Sept 2018 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Sept 2018 — TEAS STATEMENT OF USE RECEIVED